Pro-oxidant and cytotoxic effects of circulating heme

被引:547
作者
Jeney, V
Balla, J
Yachie, A
Varga, Z
Vercellotti, GM
Eaton, JW
Balla, G
机构
[1] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA
[2] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
[3] Kanazawa Univ, Dept Lab Sci, Kanazawa, Ishikawa 920, Japan
[4] Univ Debrecen, Dept Med, H-4012 Debrecen, Hungary
[5] Univ Debrecen, Dept Neonatol, H-4012 Debrecen, Hungary
关键词
D O I
10.1182/blood.V100.3.879
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Numerous pathologies may involve toxic side effects of free heme and hemederived iron. Deficiency of the hemecatabolizing enzyme, heme oxygenase-1 (HO-1), in both a human patient and transgenic knockout mice leads to an abundance of circulating heme and damage to vascular endothelium. Although heme can be directly cytotoxic, the present investigations examine the possibility that hemoglobin-derived heme and iron might be indirectly toxic through the generation of oxidized forms of low-density lipoprotein (LDL). In support, hemoglobin in plasma, when oxidized to methemoglobin by oxidants such as leukocyte-derived reactive oxygen, causes oxidative modification of LDL. Heme, released from methemogiobin, catalyzes the oxidation of LDL, which in turn induces endothelial cytolysis primarily caused by lipid hydroperoxides. Exposure of endothelium to sublethal concentrations of this oxidized LDL leads to induction of both HO-1 and ferritin. Similar endothelial cytotoxicity was caused by LDL isolated from plasma of an HO-1-deficient child. Spectral analysis of the child's plasma revealed a substantial oxidation of plasma hemoglobin to methemoglobin. Iron accumulated in the HO-1-deficient child's LDL and several independent assays revealed oxidative modification of the LDL. We conclude that hemoglobin, when oxidized in plasma, can be. indirectly cytotoxic through the generation of oxidized LDL by released heme and that, in response, the intracellular defense-HO-1 and ferritin-Is induced. These results may be relevant to a variety of disorders-such as renal failure associated with intravascular hemolysis, hemorrhagic injury to the central nervous system, and, perhaps, atherogenesis-in which hemoglobin-derived heme may promote the formation of fatty acid hydroperoxides. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:879 / 887
页数:9
相关论文
共 73 条
[1]
TRANSFECTION OF THE HUMAN HEME OXYGENASE GENE INTO RABBIT CORONARY MICROVESSEL ENDOTHELIAL-CELLS - PROTECTIVE EFFECT AGAINST HEME AND HEMOGLOBIN TOXICITY [J].
ABRAHAM, NG ;
LAVROVSKY, Y ;
SCHWARTZMAN, ML ;
STOLTZ, RA ;
LEVERE, RD ;
GERRITSEN, ME ;
SHIBAHARA, S ;
KAPPAS, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (15) :6798-6802
[2]
AGARWAL A, 1996, AM J PHYSIOL, V271, P814
[3]
HEMIN - A POSSIBLE PHYSIOLOGICAL MEDIATOR OF LOW-DENSITY-LIPOPROTEIN OXIDATION AND ENDOTHELIAL INJURY [J].
BALLA, G ;
JACOB, HS ;
EATON, JW ;
BELCHER, JD ;
VERCELLOTTI, GM .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (06) :1700-1711
[4]
BALLA G, 1991, LAB INVEST, V64, P648
[5]
BALLA G, 1992, J BIOL CHEM, V267, P18148
[6]
Ferriporphyrins and endothelium: a 2-edged sword - promotion of oxidation and induction of cytoprotectants [J].
Balla, J ;
Balla, G ;
Jeney, V ;
Kakuk, G ;
Jacob, HS ;
Vercellotti, GM .
BLOOD, 2000, 95 (11) :3442-3450
[7]
ENDOTHELIAL-CELL HEME OXYGENASE AND FERRITIN INDUCTION IN RAT LUNG BY HEMOGLOBIN IN-VIVO [J].
BALLA, J ;
NATH, KA ;
BALLA, G ;
JUCKETT, MB ;
JACOB, HS ;
VERCELLOTTI, GM .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 268 (02) :L321-L327
[8]
ENDOTHELIAL-CELL HEME UPTAKE FROM HEME-PROTEINS - INDUCTION OF SENSITIZATION AND DESENSITIZATION TO OXIDANT DAMAGE [J].
BALLA, J ;
JACOB, HS ;
BALLA, G ;
NATH, K ;
EATON, JW ;
VERCELLOTTI, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (20) :9285-9289
[9]
VITAMIN-E, LDL, AND ENDOTHELIUM - BRIEF ORAL VITAMIN SUPPLEMENTATION PREVENTS OXIDIZED LDL-MEDIATED VASCULAR INJURY IN-VITRO [J].
BELCHER, JD ;
BALLA, J ;
BALLA, G ;
JACOBS, DR ;
GROSS, M ;
JACOB, HS ;
VERCELLOTTI, GM .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (12) :1779-1789
[10]
BRUNE B, 1987, MOL PHARMACOL, V32, P497